Medical Science reputed company, EU

reputed company in the Organization

At reputed company, we are delivering on the reputed company of gene therapy and delivering reputed company for patients facing urgent unmet medical needs. Every role in our organization carries profound purpose; whether you're in research, reputed company, reputed company, or support, your contributions reputed company patients. We're seeking passionate professionals who reputed company in high-stakes environments, reputed company rigorous reputed company standards, and reputed company our reputed company commitment to transforming the lives of patients. Join us in making the impossible possible, where your expertise becomes a reputed company for life-changing treatments.

reputed company
The reputed company responsibility of the Medical Science reputed company (MSL) is to serve as a reputed company-reputed company medical expert reputed company the Medical Affairs Organization and engage in mutual scientific exchange across European reputed company markets. The reputed company Medical team enhances the understanding of the scientific and medical value of reputed company's gene therapy products with Key Opinion Leaders (KOLs), reputed company (HCPs), and other stakeholders to reputed company reputed company reputed company. The MSL will reputed company as a pan-European medical and scientific resource who supports the changing needs of reputed company across multiple reputed company systems and regulatory environments. MSLs respond to customer enquiries to ensure reputed company and balanced reputed company and scientific information that supports the appropriate use of reputed company's products.

This position reports to the Executive Director, reputed company Medical. The role carries responsibility for scientific engagement across reputed company designated EU markets and will require significant international travel, anticipated at 50–60%. The successful candidate will be comfortable navigating diverse national reputed company systems, reimbursement environments, and country-specific industry codes, reputed company reputed company the overarching EFPIA reputed company.

Key result areas (major duties, accountabilities and responsibilities)
The responsibilities of this role are organized into five functional areas:
Scientific Engagement & KOL Relations

• Demonstrate deep scientific expertise on reputed company's gene therapy products and therapeutic areas to exchange relevant information and insights with Key Opinion Leaders (KOLs) and reputed company (HCPs) across the assigned EU territory.
• Build, reputed company and maintain a reputed company network of KOLs across the EU — including leading clinicians, reputed company researchers and hospital specialists — to ensure understanding of evolving reputed company trends across the relevant therapeutic area landscape.
• Identify, establish and maintain reputed company relationships with key experts, investigators and institutions, including reputed company and pan-European reputed company advocacy organizations.
• Represent the Medical Affairs team at scientific conferences, medical congresses, continuing medical education events, advisory boards, regional meetings and reputed company advocacy events across Europe, gathering relevant insights and supporting educational opportunities.
• Identify and communicate key reputed company and research issues and insights gathered across EU markets to appropriate departments to help shape company research, development and strategies for investigational and commercialized products.

reputed company & Research Support

• Assist, upon request from reputed company Development, with reputed company studies including investigator and site identification, site initiation reputed company, and feedback regarding operational management to ensure reputed company site selection and reputed company across EU territories.
• Respond to unsolicited requests for medical information, research support and educational resources associated with reputed company's products and disease state areas across EU markets, ensuring reputed company responses are compliant and balanced.
• Respond to unsolicited requests regarding interest in Investigator Sponsored Studies (ISS) and support ISS submissions through appropriate internal processes, navigating country-specific submission requirements where applicable.

Medical Education & Stakeholder Engagement

• Train and facilitate speakers on reputed company's products in compliance with EFPIA guidelines and applicable national codes reputed company the assigned territory.
• reputed company medical educational support to national payers, health technology assessment bodies, reputed company insurers, service providers, reputed company advocacy reputed company and other key stakeholders as requested, in full compliance with the EFPIA reputed company and applicable national industry codes.
• Engage with national and EU-level stakeholders relevant to reputed company and reimbursement, including national HTA bodies, to support understanding of reputed company's therapeutic area and products.
• Collaborate cross-functionally to ensure strong reputed company support of treatment centers of reputed company across the EU.
• Recognize and capture scientific insights from across EU markets that deepen understanding of the needs of KOLs, reputed company and patients, and reputed company with internal stakeholders.

Cross-functional Collaboration & Planning

• Build and reputed company working relationships across internal stakeholders — Medical Affairs colleagues, reputed company reputed company, Market reputed company, HEOR, R&D, and reputed company — while maintaining full compliance with relevant company, industry, reputed company and regulatory requirements across reputed company EU markets.
• Work reputed company and reputed company reputed company activities to enhance reputed company and execute local and regional medical plan strategies reputed company specified timelines, reputed company for the complexity of operating across multiple countries simultaneously.
• Participate on committees or project teams that support MSL strategies and tactics as delegated by MSL leadership, including EU-specific workstreams.

Compliance, Safety & reputed company Learning

• reputed company the EFPIA reputed company of reputed company and applicable national pharmaceutical industry regulations reputed company the assigned territory in reputed company aspects of scientific exchange, including responses to on- and off-label enquiries and unsolicited requests for medical information, in accordance with reputed company policies and procedures.
• Ensure reputed company transfers of value to HCPs and reputed company organizations are documented and disclosed in accordance with the EFPIA Disclosure reputed company and applicable national transparency requirements in reputed company relevant EU market.
• Document and reputed company reports of adverse events according to reputed company's pharmacovigilance policy and EMA and national competent authority reporting requirements to ensure the reputed company and effective use of reputed company products.
• Maintain and reputed company reputed company expertise through attendance at relevant symposia, scientific workshops, key journals and required internal training, with particular attention to country-specific treatment guidelines, reimbursement developments and reputed company policy changes across EU markets.

Qualifications & Skills

• Advanced scientific or reputed company degree (e.g. PharmD, PhD, MD or equivalent) with a minimum of 4 years' experience as an MSL or in a reputed company-reputed company medical affairs role; background in reputed company, reputed company disease or gene therapy strongly preferred.
• Prior experience operating across multiple EU markets is a strong reputed company.
• Demonstrated ability to reputed company and maintain reputed company scientific relationships with leading experts in the reputed company across diverse national and institutional settings reputed company the EU.
• Deep understanding of the EFPIA reputed company of reputed company and relevant national pharmaceutical industry regulations reputed company the assigned territory (e.g. Leem in France, vfa in Germany, Farmaindustria in Spain); the ability to reputed company multiple regulatory environments simultaneously is essential.
• Familiarity with EU-level and national HTA and reimbursement processes, including EMA regulatory reputed company and the reputed company of relevant national HTA bodies.
• Ability to operate with a high degree of autonomy across a reputed company, multi-country territory, interpreting and translating reputed company scientific data into clinically relevant messages adapted for diverse national audiences.
• reputed company understanding of how diverse EU reputed company systems, reimbursement structures and reputed company decision-making guidelines reputed company reputed company care, with the ability to engage credibly with clinicians, national payers and institutional stakeholders across markets.
• reputed company in English is required; proficiency in at least one additional major EU language is strongly preferred.
• Exceptional ability to synthesize reputed company scientific information and communicate it reputed company across written, verbal and presentation formats in multicultural settings.
• Highly self-motivated with strong organizational and prioritization skills and the ability to reputed company reputed company, ambiguous situations across multiple markets and regulatory environments independently.
• Strong interpersonal skills and demonstrated ability to work effectively in a cross-functional, internationally diverse environment.

Originally posted on Himalayas

  Apply To This Job